These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 8891007

  • 41. Serum TNF-alpha, sCD8 and sIL-2R levels in childhood tuberculosis.
    Barlan IB, Başaran MM, Bakir M, Tükenmez F, Bekiroğlu N.
    Infection; 1995; 23(4):237-9. PubMed ID: 8522383
    [Abstract] [Full Text] [Related]

  • 42. Serum soluble interleukin-2 receptor in eosinophilia.
    Kaito K, Otsubo H, Ogasawara Y, Kimura H, Kurihara E, Koike M, Aiso M, Kobayashi M.
    Acta Haematol; 2003; 109(1):23-8. PubMed ID: 12486319
    [Abstract] [Full Text] [Related]

  • 43. Effects of cyclosporine A on serum and urinary soluble interleukin-2 receptor in patients with lupus nephritis.
    Tang Z, Zhang J, Zhang S, Li L.
    Chin Med J (Engl); 1997 Sep; 110(9):686-9. PubMed ID: 9642325
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Soluble interleukin-2 receptor is a thyroid hormone-dependent early-response marker in the treatment of thyrotoxicosis.
    Smallridge RC, Tsokos GC, Burman KD, Porter L, Cranston T, Sfikakis PP, Solomon BL.
    Clin Diagn Lab Immunol; 1997 Sep; 4(5):583-6. PubMed ID: 9302209
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Monitoring of serologic immune parameters in inflammatory skin diseases.
    Gebhardt M, Wenzel HC, Hipler UC, Herrmann D, Wollina U.
    Allergy; 1997 Nov; 52(11):1087-94. PubMed ID: 9404560
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Soluble Interleukin-2 Receptor: A Potential Marker for Monitoring Disease Activity in IgG4-Related Disease.
    Karim AF, Eurelings LEM, Bansie RD, van Hagen PM, van Laar JAM, Dik WA.
    Mediators Inflamm; 2018 Nov; 2018():6103064. PubMed ID: 29686532
    [Abstract] [Full Text] [Related]

  • 54. [Relation of serum levels of the soluble cytoadhesion molecules sVCAM-1 and sICAM-1 to selected factors in the cytokine network in multiple myeloma].
    Scudla V, Budíková M, Bacovský J, Opíchalová D, Farbiaková V.
    Cas Lek Cesk; 2000 Jul 05; 139(13):401-6. PubMed ID: 10971970
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Soluble interleukin 2 and CD8 and CD4 receptors in inflammatory bowel disease.
    Matsuura T, West GA, Klein JS, Ferraris L, Fiocchi C.
    Gastroenterology; 1992 Jun 05; 102(6):2006-14. PubMed ID: 1587419
    [Abstract] [Full Text] [Related]

  • 60. Serum soluble interleukin-2 receptor measurement in patients with sarcoidosis: a clinical evaluation.
    Grutters JC, Fellrath JM, Mulder L, Janssen R, van den Bosch JM, van Velzen-Blad H.
    Chest; 2003 Jul 05; 124(1):186-95. PubMed ID: 12853522
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.